Search research articles
Contact Us
Filters
Showing results (1-10 of 27) with videos related to
Page
of 3
Sort By:
Pediatrics
|
September 1, 1971
Hypertension associated with crossed renal ectopia in an infant
D T Mininberg, S Roze, M Pearl
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Projection of Long Term Health-Economic Benefits of Sensor Augmented Pump (Sap) Versus Pump Therapy Alone (Csii) In Type 1 Diabetes, A Uk Perspective
S Roze, M Cook, M Jethwa, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Companion Diagnostics-Targeted Therapies Pairings Model-Based Economic Evaluation: Reflection On A General Modeling Framework And Key Methodological Points
R Marty, S Roze, A Tisseau, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
December 1, 2004
The cost-effectiveness of continuous subcutaneous insulin infusion compared with multiple daily injections for the management of diabetes: response to Scuffham [corrected] and Carr
A J Palmer, S Roze, W J Valentine, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
August 20, 2005
Health-economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of Type 1 diabetes in the UK
S Roze, W J Valentine, K E Zakrzewska, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Projection of Long Term Health Economic Benefits of Sensor Augmented Pump (Sap) Versus Pump Therapy Alone (Csii) In Uncontrolled Type 1 Diabetes In France
S Roze, V Payet, F Debroucker, et al.
Current Medical Research and Opinion
|
December 15, 2006
A health economic model to determine the long-term costs and clinical outcomes of raising low HDL-cholesterol in the prevention of coronary heart disease
S Roze, D Liens, A Palmer, et al.
International Journal of Clinical Practice
|
August 31, 2006
Improving life expectancy and decreasing the incidence of complications associated with type 2 diabetes: a modelling study of HbA1c targets
W J Valentine, A J Palmer, L Nicklasson, et al.
Diabetes Research and Clinical Practice
|
April 23, 2017
Cost-effectiveness of sensor-augmented pump therapy versus standard insulin pump therapy in patients with type 1 diabetes in Denmark
S Roze, S de Portu, J Smith-Palmer, et al.
Deutsche Medizinische Wochenschrift (1946)
|
January 3, 2004
[Health economic consequences of the use of irbesartan in patients in Germany with type 2 diabetes, nephropathy and hypertension]
A J Palmer, L Annemans, S Roze, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 27) with videos related to
Sort By:
Page
of 3
Pediatrics
|
September 1, 1971
Hypertension associated with crossed renal ectopia in an infant
D T Mininberg, S Roze, M Pearl
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Projection of Long Term Health-Economic Benefits of Sensor Augmented Pump (Sap) Versus Pump Therapy Alone (Csii) In Type 1 Diabetes, A Uk Perspective
S Roze, M Cook, M Jethwa, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Companion Diagnostics-Targeted Therapies Pairings Model-Based Economic Evaluation: Reflection On A General Modeling Framework And Key Methodological Points
R Marty, S Roze, A Tisseau, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
December 1, 2004
The cost-effectiveness of continuous subcutaneous insulin infusion compared with multiple daily injections for the management of diabetes: response to Scuffham [corrected] and Carr
A J Palmer, S Roze, W J Valentine, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
August 20, 2005
Health-economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of Type 1 diabetes in the UK
S Roze, W J Valentine, K E Zakrzewska, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Projection of Long Term Health Economic Benefits of Sensor Augmented Pump (Sap) Versus Pump Therapy Alone (Csii) In Uncontrolled Type 1 Diabetes In France
S Roze, V Payet, F Debroucker, et al.
Current Medical Research and Opinion
|
December 15, 2006
A health economic model to determine the long-term costs and clinical outcomes of raising low HDL-cholesterol in the prevention of coronary heart disease
S Roze, D Liens, A Palmer, et al.
International Journal of Clinical Practice
|
August 31, 2006
Improving life expectancy and decreasing the incidence of complications associated with type 2 diabetes: a modelling study of HbA1c targets
W J Valentine, A J Palmer, L Nicklasson, et al.
Diabetes Research and Clinical Practice
|
April 23, 2017
Cost-effectiveness of sensor-augmented pump therapy versus standard insulin pump therapy in patients with type 1 diabetes in Denmark
S Roze, S de Portu, J Smith-Palmer, et al.
Deutsche Medizinische Wochenschrift (1946)
|
January 3, 2004
[Health economic consequences of the use of irbesartan in patients in Germany with type 2 diabetes, nephropathy and hypertension]
A J Palmer, L Annemans, S Roze, et al.
Page
of 3